Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-143
Closed -$21K – 1463
2025
Q3
$21K Buy
143
+5
+4% +$693 0.01% 543
2025
Q2
$17.9K Hold
138
– – 0.01% 603
2025
Q1
$16.5K Buy
138
+3
+2% +$372 0.01% 626
2024
Q4
$15.7K Hold
135
– – 0.01% 798
2024
Q3
$18.2K Hold
135
– – 0.01% 752
2024
Q2
$18.3K Buy
135
+11
+9% +$1.5K 0.01% 691
2024
Q1
$16.1K Buy
+124
New +$15K 0.01% 817

Other funds holding XYL

Rise Advisors's XYL Position: Q4 2025 in Review

Rise Advisors sold out of Xylem (XYL) in Q4 2025, closing a stake of 143 shares — an estimated $21K sold.

Rise Advisors first reported a position in XYL in Q1 2024 and held it in 7 quarters. The position peaked at $21K in Q3 2025. 1,135 funds tracked by Wall St. Rank hold XYL as of Q4 2025.

  • Rise Advisors reported no remaining Xylem position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 143 Xylem shares in Q4 2025, an estimated $21K.
  • Rise Advisors first reported a position in Xylem in Q1 2024 and held it in 7 quarters.
  • Rise Advisors's Xylem position peaked at $21K in Q3 2025.
  • 1,135 funds tracked by Wall St. Rank held Xylem as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.